New hope for chinese patients with stubborn chronic GVHD

NCT ID NCT06843408

First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 28 times

Summary

This study tests a drug called axatilimab in Chinese patients who have chronic graft-versus-host disease (cGVHD) that did not get better with other treatments. cGVHD is a complication after a stem cell transplant where the donor cells attack the patient's body. The goal is to see if axatilimab is safe and can reduce symptoms. About 30 participants aged 12 and older will take the drug and be monitored for side effects and response.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC GRAFT VERSUS HOST DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Institute of Hematology, Chinese Academy of Medical Sciences

    RECRUITING

    Tianjin, 301617, China

  • Nanfang Hospital of Southern Medical University

    RECRUITING

    Guangzhou, 510515, China

  • Peking University People'S Hospital

    RECRUITING

    Beijing, 101149, China

  • Shanghai Children'S Medical Center

    RECRUITING

    Shanghai, 200127, China

  • The First Affiliated Hospital, Zhejiang University School of Medicine

    RECRUITING

    Hangzhou, 310024, China

  • The Second Affiliated Hospital, Army Medical University (Xinqiao Hospital)

    RECRUITING

    Chongoing, 400037, China

  • Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology

    RECRUITING

    Wuhan, 430022, China

  • West China Hospital of Sichuan University

    RECRUITING

    Chengdu, 610041, China

  • Zhujiang Hospital of Southern Medical University

    RECRUITING

    Guangzhou, 510280, China

Conditions

Explore the condition pages connected to this study.